Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers

  • Hamaguchi M
  • Kawahito Y
  • Tsubouchi Y
 et al. 
  • 8


    Mendeley users who have this article in their library.
  • 2


    Citations of this article.


Conventional treatment is not standardized for hepatitis C virus-negative cryoglobulinemia, but corticosteroids, immunosuppressive agents, and plasma exchange typically improved the symptoms. Mizoribine is an immunosuppressive agent that was developed in Japan and has been found to inhibit the proliferation of lymphocytes, especially B cells. We have encountered an elder patient who had hepatitis C virus-negative, type II cryoglobulinemic vasculitis with leg purpura and skin ulcers. Her symptoms improved and cryoglobulin disappeared by the combination therapy of prednisolone and mizoribine. We speculate the action mechanism of this therapy is due to immunosuppressive effects including up-regulation of the efficacy of prednisolone by mizoribine.

Author-supplied keywords

  • Cryoglobulin
  • Cryoglobulinemia
  • Mizoribine
  • Skin ulcer
  • Vasculitis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Masahide HamaguchiKyoto Prefectural University of Medicine, Graduate School of Medical Science

  • Yutaka Kawahito

  • Yasunori Tsubouchi

  • Masataka Kohno

  • Aihiro Yamamoto

  • Hidetaka Ishino

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free